Credit Suisse’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-97,328
| Closed | -$389K | – | 3597 |
|
2019
Q4 | $389K | Buy |
97,328
+41,264
| +74% | +$165K | ﹤0.01% | 3042 |
|
2019
Q3 | $275K | Buy |
56,064
+13,886
| +33% | +$68.1K | ﹤0.01% | 3074 |
|
2019
Q2 | $257K | Buy |
42,178
+348
| +0.8% | +$2.12K | ﹤0.01% | 3117 |
|
2019
Q1 | $243K | Buy |
41,830
+980
| +2% | +$5.69K | ﹤0.01% | 3113 |
|
2018
Q4 | $550K | Buy |
40,850
+8,321
| +26% | +$112K | ﹤0.01% | 2680 |
|
2018
Q3 | $631K | Sell |
32,529
-60,027
| -65% | -$1.16M | ﹤0.01% | 2710 |
|
2018
Q2 | $2.37M | Sell |
92,556
-6,845
| -7% | -$175K | ﹤0.01% | 1946 |
|
2018
Q1 | $2M | Buy |
99,401
+28,220
| +40% | +$568K | ﹤0.01% | 2060 |
|
2017
Q4 | $1.43M | Buy |
71,181
+21,335
| +43% | +$428K | ﹤0.01% | 2286 |
|
2017
Q3 | $1.03M | Buy |
49,846
+24,887
| +100% | +$515K | ﹤0.01% | 2619 |
|
2017
Q2 | $369K | Sell |
24,959
-25,827
| -51% | -$382K | ﹤0.01% | 2974 |
|
2017
Q1 | $810K | Sell |
50,786
-27,027
| -35% | -$431K | ﹤0.01% | 2667 |
|
2016
Q4 | $980K | Buy |
77,813
+38,237
| +97% | +$482K | ﹤0.01% | 2714 |
|
2016
Q3 | $1.11M | Sell |
39,576
-7,220
| -15% | -$202K | ﹤0.01% | 2555 |
|
2016
Q2 | $1.64M | Buy |
46,796
+11,507
| +33% | +$403K | ﹤0.01% | 2246 |
|
2016
Q1 | $967K | Buy |
35,289
+3,493
| +11% | +$95.7K | ﹤0.01% | 2478 |
|
2015
Q4 | $1.09M | Sell |
31,796
-3,309
| -9% | -$113K | ﹤0.01% | 2548 |
|
2015
Q3 | $1.01M | Sell |
35,105
-2,967
| -8% | -$85.3K | ﹤0.01% | 2635 |
|
2015
Q2 | $1.7M | Buy |
38,072
+27,037
| +245% | +$1.21M | ﹤0.01% | 2448 |
|
2015
Q1 | $382K | Sell |
11,035
-1,814
| -14% | -$62.8K | ﹤0.01% | 3451 |
|
2014
Q4 | $352K | Buy |
+12,849
| New | +$352K | ﹤0.01% | 3587 |
|